Table 3. Prediction of resistance to IVIG on logistic regression analysis in the NT-proBNP group selected through propensity score matching
| Variables | Univariate analysis | Multivariate analysis |
| OR | 95% CI | Nagelkerke R2 | P value | OR | 95% CI | P value |
| Male gender | 1.489 | 1.184–1.873 | 0.009 | 0.001 | 1.649 | 1.294–2.101 | < 0.001 |
| Age (year) | 1.069 | 1.013–1.128 | 0.004 | 0.016 | | | |
| Height (cm) | 1.013 | 1.006–1.019 | 0.010 | < 0.001 | | | |
| BSA (m2) | 2.474 | 1.330–4.601 | 0.006 | 0.004 | 1.309 | 0.570–3.009 | 0.526 |
| Complete presentation | 1.630 | 1.222–2.175 | 0.009 | 0.001 | 1.305 | 0.963–1.770 | 0.086 |
| Neutrophil (%) | 1.039 | 1.031–1.047 | 0.073 | < 0.001 | 1.029 | 1.019–1.039 | < 0.001 |
| Hemoglobin (g/dL) | 0.884 | 0.793–0.986 | 0.004 | 0.027 | 0.800 | 0.700–0.914 | 0.001 |
| Platelet (× 1,000 /μL) | 0.998 | 0.997–0.999 | 0.011 | < 0.001 | 0.998 | 0.997–0.999 | 0.002 |
| CRP (mg/dL) | 1.046 | 1.029–1.062 | 0.024 | < 0.001 | 1.008 | 0.998–1.018 | 0.134 |
| Albumin (g/dL) | 0.553 | 0.431–0.708 | 0.016 | < 0.001 | 0.831 | 0.627–1.100 | 0.195 |
| AST (U/L) | 1.001 | 1.001–1.002 | 0.020 | < 0.001 | | | |
| ALT (U/L) | 1.002 | 1.001–1.002 | 0.017 | < 0.001 | 1.001 | 1.000–1.001 | 0.100 |
| Total bilirubin (mg/dL) | 1.653 | 1.476–1.851 | 0.058 | < 0.001 | 1.297 | 1.144–1.470 | < 0.001 |
| Na+ (mEq/L) | 0.903 | 0.865–0.942 | 0.016 | < 0.001 | 0.975 | 0.930–1.021 | 0.281 |
| NT-proBNP (pg/mL) | 1.000 | 1.000–1.000 | 0.015 | < 0.001 | | | |
| LT-NT-proBNP | 1.255 | 1.161–1.356 | 0.025 | < 0.001 | | | |
| Z score | 1.399 | 1.247–1.569 | 0.025 | < 0.001 | 1.153 | 1.017–1.308 | 0.026 |
| Pyuria | 1.390 | 1.112–1.738 | 0.006 | 0.004 | 0.971 | 0.757–1.246 | 0.817 |
IVIG: intravenous immunoglobulin; NT-proBNP: N-terminal pro-B-type natriuretic peptide; OR: odds ratio; CI: confidence interval; BSA: body surface area; CRP: C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LT-NT-proBNP: log transformed NT-proBNP.